Literature DB >> 7472561

A synthetic dural prosthesis constructed from hydroxyethylmethacrylate hydrogels.

S Bhatia1, P R Bergethon, S Blease, T Kemper, A Rosiello, G P Zimbardi, C Franzblau, E L Spatz.   

Abstract

Hydroxyethylmethacrylate (HEMA) hydrogels were investigated for their suitability as a dural prosthesis. Poly-HEMA has many characteristics required for an artificial dural substitute: it is durable, flexible, easily prepared, inexpensive, easily sterilized and handled, easily shaped, and known to be chemically inert and nontoxic. Sheets made of plain HEMA were evaluated as dural substitutes in rats and rabbits after either craniotomy or laminectomy with durectomy. Histological evaluations of the prostheses and the underlying tissues were undertaken at various time points from 2 to 9 weeks postoperatively. There was minimal tissue response to the implanted HEMA gel in contrast to marked thickening of the overlying leptomeninges and cortical herniation in the control animals. It is concluded that HEMA gels fulfill the essential criteria for an effective dural substitute.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472561     DOI: 10.3171/jns.1995.83.5.0897

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  Radially aligned, electrospun nanofibers as dural substitutes for wound closure and tissue regeneration applications.

Authors:  Jingwei Xie; Matthew R Macewan; Wilson Z Ray; Wenying Liu; Daku Y Siewe; Younan Xia
Journal:  ACS Nano       Date:  2010-09-28       Impact factor: 15.881

2.  Resorbable polyacrylic hydrogels derived from vitamin E and their application in the healing of tendons.

Authors:  M A Plasencia; C Ortiz; B Vázquez; J San Román; A López-Bravo; A López-Alonso
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

3.  Rheological properties of poly(2-hydroxyethyl methacrylate) (pHEMA) as a function of water content and deformation frequency.

Authors:  J R Meakin; D W L Hukins; R M Aspden; C T Imrie
Journal:  J Mater Sci Mater Med       Date:  2003-09       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.